MDB Capital Holdings forms subsidiary to license Mayo senescence platform

MDB Capital Holdings, LLC

MDB Minnesota One entered a license agreement with Mayo Foundation for $150k upfront fee plus royalties.
MDB owns 67% and Mayo 33% of Minnesota One as of the license date.
MDB may invest up to $5M over 5 years via a Term Equity Purchase Agreement.
Minnesota One aims to develop a small molecule senescence platform and eventually list on a national exchange.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.